H. Sinzinger

8.2k total citations
421 papers, 5.2k citations indexed

About

H. Sinzinger is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Pharmacology. According to data from OpenAlex, H. Sinzinger has authored 421 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 118 papers in Surgery, 104 papers in Cardiology and Cardiovascular Medicine and 83 papers in Pharmacology. Recurrent topics in H. Sinzinger's work include Inflammatory mediators and NSAID effects (66 papers), Antiplatelet Therapy and Cardiovascular Diseases (64 papers) and Lipoproteins and Cardiovascular Health (60 papers). H. Sinzinger is often cited by papers focused on Inflammatory mediators and NSAID effects (66 papers), Antiplatelet Therapy and Cardiovascular Diseases (64 papers) and Lipoproteins and Cardiovascular Health (60 papers). H. Sinzinger collaborates with scholars based in Austria, Italy and Germany. H. Sinzinger's co-authors include A. Oguogho, John O’Grady, Roswitha Wolfram, Irene Virgolini, K Silberbauer, P Fitscha, Grazyna Sobal, J Kaliman, Christian Pirich and Bernhard A. Peskar and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Hepatology.

In The Last Decade

H. Sinzinger

402 papers receiving 4.9k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
H. Sinzinger 1.3k 1.1k 798 672 660 421 5.2k
Uzi Gafter 1.2k 0.9× 710 0.6× 1.0k 1.3× 644 1.0× 617 0.9× 174 6.8k
R. Paoletti 1.8k 1.3× 2.0k 1.8× 1.4k 1.7× 689 1.0× 846 1.3× 182 5.8k
Franco Cuccurullo 1.8k 1.3× 2.6k 2.4× 1.5k 1.9× 985 1.5× 741 1.1× 193 9.1k
Paulette Mehta 698 0.5× 1.6k 1.5× 686 0.9× 654 1.0× 353 0.5× 182 4.7k
Masayuki Yokode 1.5k 1.1× 876 0.8× 1.6k 2.0× 734 1.1× 734 1.1× 141 5.8k
Francesco Cipollone 1.5k 1.1× 1.6k 1.5× 1.6k 2.1× 854 1.3× 908 1.4× 194 8.1k
Suminori Kono 1.5k 1.1× 464 0.4× 1.3k 1.7× 791 1.2× 759 1.1× 205 7.1k
P. Schollmeyer 1.2k 0.9× 720 0.7× 1.2k 1.5× 659 1.0× 484 0.7× 281 6.0k
Rodolfo Paoletti 3.7k 2.8× 1.6k 1.4× 2.2k 2.8× 819 1.2× 1.1k 1.7× 132 8.7k
Bobby V. Khan 905 0.7× 1.3k 1.2× 842 1.1× 689 1.0× 583 0.9× 71 4.2k

Countries citing papers authored by H. Sinzinger

Since Specialization
Citations

This map shows the geographic impact of H. Sinzinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Sinzinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Sinzinger more than expected).

Fields of papers citing papers by H. Sinzinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Sinzinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Sinzinger. The network helps show where H. Sinzinger may publish in the future.

Co-authorship network of co-authors of H. Sinzinger

This figure shows the co-authorship network connecting the top 25 collaborators of H. Sinzinger. A scholar is included among the top collaborators of H. Sinzinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Sinzinger. H. Sinzinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Palumbo, Barbara & H. Sinzinger. (2012). The Fukushima nuclear accident temporarily increased patients reluctance for nuclear medicine investigations.. PubMed. 15(1). 28–32. 1 indexed citations
2.
Oguogho, A., et al.. (2010). Prickly pear changes 111indium–LDL and 111indium–HDL platelet binding Correlating to improvement of platelet function in hypercholesterolemia. 12. 67–79. 4 indexed citations
3.
Wolfram, Roswitha, A. Oguogho, Barbara Palumbo, & H. Sinzinger. (2004). Enhanced Oxidative Stress in Coronary Heart Disease and Chronic Heart Failure as Indicated by an Increased 8-epi-PGF2α. European Journal of Heart Failure. 7(2). 167–172. 50 indexed citations
4.
Aghajanian, Amir, et al.. (2002). Accumulation of Tc-99m-MIBI and Tc-99m-tetrofosmin in tumor cells. Uptake and washout studies. World Journal of Nuclear Medicine. 1. 1 indexed citations
5.
Obwegeser, R., Andreas Obruca, Leo Auerbach, E. Kubista, & H. Sinzinger. (1999). Axillary Metastases of an Occult Primary Carcinoma of the Breast—Discovered Only by99mTc-Tetrofosmin Scintigraphy. Gynecologic Oncology. 72(3). 418–420. 4 indexed citations
6.
Aull, S, et al.. (1996). Dynamic changes of plasma lipids and lipoproteins in patients after transient ischemic attack or minor stroke. The American Journal of Medicine. 101(3). 291–298. 24 indexed citations
7.
Virgolini, Irene, Gabriela Kornek, Shuren Li, et al.. (1993). Scintigraphic evaluation of functional hepatic mass in patients with advanced breast cancer. British Journal of Cancer. 68(3). 549–554. 15 indexed citations
8.
Diehm, C., H. Sinzinger, & W. Rogatti. (1991). Prostaglandin E[1] : new aspects on pharmacology, metabolism, and clinical efficacy. Springer eBooks. 10 indexed citations
9.
Virgolini, Irene, et al.. (1991). Quantification of human hepatic binding protein (HBP) via 99mTc-galactosyl-neoglycoalbumin (NGA) liver scintigraphy.. PubMed. 103(15). 458–61. 3 indexed citations
10.
Virgolini, Irene, P Fitscha, H. Sinzinger, & H. Barth. (1990). Effects of taprostene, a stable prostacyclin analogue, on haemodynamics, platelet function and arachidonate metabolism in healthy volunteers. European Journal of Clinical Pharmacology. 38(4). 347–350. 8 indexed citations
11.
Sinzinger, H., H. Sinzinger, P Fitscha, et al.. (1990). Synergistic effect of prostaglandin E1 and isosorbide dinitrate in peripheral vascular disease. The Lancet. 335(8690). 627–628. 41 indexed citations
12.
Sinzinger, H., Irene Virgolini, & J. O’Grady. (1989). Clinical trials of PGE1, PGI2 and mimetics in patients with peripheral vascular disease.. PubMed. 301. 85–96. 11 indexed citations
13.
Sinzinger, H. & G. Weber. (1988). Reduced biological half-life of plasma prostacyclin in pre-eclampsia. Archives of Gynecology and Obstetrics. 243(4). 187–190. 2 indexed citations
14.
Watzek, Georg, et al.. (1987). [Indium-111-bleomycin scintigraphy for imaging squamous cell carcinoma of the oromaxillofacial region].. PubMed. 32. 184–5.
15.
Burghuber, Otto C., et al.. (1986). Inhibition of Acetylcholine-Induced Bronchoconstriction in Asthmatics by Nifedipine. Respiration. 50(4). 265–272. 2 indexed citations
16.
Husslein, Peter, et al.. (1985). Prostacyclin Does Not Influence Placental Blood Pool in vivo. Gynecologic and Obstetric Investigation. 19(2). 78–81. 3 indexed citations
17.
Matĕjka, M, et al.. (1984). [Scintigraphy using 111-indium-oxine-sulfate-labeled autologous granulocytes compared to scintigraphy using 99-Tc-pyrophosphate in inflammations of the jaw region].. PubMed. 96(3). 117–9.
18.
Sinzinger, H. & P Fitscha. (1984). Scintigraphic detection of femoral artery atherosclerosis with 111-indium-labeled autologous platelets.. PubMed. 13(4). 350–3. 5 indexed citations
19.
Sinzinger, H., et al.. (1980). Does Prostacyclin (PGI<sub>2</sub>) Regulate Human Arterial Intima Smooth Muscle Cell Proliferation in Early Atherogenesis?. Journal of Vascular Research. 17(1). 58–60. 7 indexed citations
20.
Silberbauer, K, et al.. (1977). [Arterial radiation injuries].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 6(2). 183–5. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026